Hans Schlosser
Overview
Explore the profile of Hans Schlosser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baehr F, Teloh-Benger J, Damanakis A, Gebauer F, Schlosser H, Schroeder W, et al.
Surg Oncol
. 2025 Jan;
58:102184.
PMID: 39756157
Background: Esophageal cancer (EC) is a disease with a poor prognosis. While treatment options have been improved, there is no consensus for surveillance strategies following therapy with curative intent. As...
2.
Seifert N, Reinke S, Grund J, Muller-Meinhard B, Richter J, Heilmann T, et al.
Leukemia
. 2024 Dec;
39(3):684-693.
PMID: 39690183
The Tumor Microenvironment (TME) in classical Hodgkin Lymphoma (HL) contains abundant immune cells and only few neoplastic Hodgkin and Reed-Sternberg cells (HRSC). We analyzed the T-cell receptor (TCR) repertoire to...
3.
Bremm J, Brunner S, Celik E, Damanakis A, Schlosser H, Fuchs H, et al.
Eur J Surg Oncol
. 2024 Feb;
50(4):108003.
PMID: 38401351
Introduction: In esophageal cancer, histopathologic response following neoadjuvant therapy and transthoracic esophagectomy is a strong predictor of long-term survival. At the present, it is not known whether the initial tumor...
4.
Tsakmaklis A, Farowski F, Zenner R, Lesker T, Strowig T, Schlosser H, et al.
BMC Cancer
. 2023 Nov;
23(1):1160.
PMID: 38017389
Background: Composition of the intestinal microbiota has been correlated to therapeutic efficacy of immune checkpoint inhibitors (ICI) in various cancer entities including melanoma. Prediction of the outcome of such therapy,...
5.
Muller D, Babic B, Herbst V, Gebauer F, Schlosser H, Schiffmann L, et al.
Cancers (Basel)
. 2020 Dec;
12(11).
PMID: 33266414
Anastomotic leak is one of the most severe postoperative complications and is therefore considered a benchmark for the quality of surgery for esophageal cancer. There is substantial debate on which...
6.
Reinke S, Brockelmann P, Iaccarino I, Garcia-Marquez M, Borchmann S, Jochims F, et al.
Blood
. 2020 Oct;
136(25):2851-2863.
PMID: 33113552
Classic Hodgkin lymphoma (cHL) is the cancer type most susceptible to antibodies targeting programmed cell death protein 1 (PD1) and is characterized by scarce Hodgkin and Reed-Sternberg cells (HRSCs), perpetuating...
7.
Kramer M, Plum P, Velazquez Camacho O, Folz-Donahue K, Thelen M, Garcia-Marquez I, et al.
Mol Oncol
. 2020 Apr;
14(6):1170-1184.
PMID: 32255255
Single-cell transcriptomics have revolutionized our understanding of the cell composition of tumors and allowed us to identify new subtypes of cells. Despite rapid technological advancements, single-cell analysis remains resource-intense hampering...
8.
Zhao Y, Li J, Li D, Wang Z, Zhao J, Wu X, et al.
Semin Cancer Biol
. 2019 Aug;
60:334-343.
PMID: 31445220
More than 70% of gastrointestinal (GI) cancers are diagnosed with metastases, leading to poor prognosis. For some cancer patients with limited sites of metastatic tumors, the term oligometastatic disease (OMD)...
9.
Kobold S, Krackhardt A, Schlosser H, Wolf D
Dtsch Med Wochenschr
. 2018 Jul;
143(14):1006-1013.
PMID: 30005434
Pioneering work has unraveled the role of the immune system in the development and control of cancer. This knowledge has set the basis for the successful implementation of immunotherapy into...
10.
Lechner A, Schlosser H, Rothschild S, Thelen M, Reuter S, Zentis P, et al.
Oncotarget
. 2017 Jun;
8(27):44418-44433.
PMID: 28574843
The composition of tumor-infiltrating lymphocytes (TIL) reflects biology and immunogenicity of cancer. Here, we characterize T-cell subsets and expression of immune checkpoint molecules in head and neck squamous cell carcinoma...